Patents by Inventor Alicia Mildred TYRELL

Alicia Mildred TYRELL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mesenchymal stem cells expressing TNF-? receptors
    Patent number: 11821004
    Abstract: Mesenchymal stem cells which express TNF-? receptor Type I in an amount of at least 13 pg/106 cells. Such mesenchymal stem cells inhibit the proliferation of lymphocytes and may be employed, in particular, in the treatment of graft-versus-host disease.
    Type: Grant
    Filed: November 2, 2020
    Date of Patent: November 21, 2023
    Assignee: MESOBLAST INTERNATIONAL SÁRL
    Inventors: Alla Danilkovitch, Diane Carter, Alicia Mildred Tyrell, Simon Bubnic, Michelle Marcelino, Rodney Monroy
  • Mesenchymal Stem Cells Expressing TNF-alpha Receptors
    Publication number: 20210171913
    Abstract: Mesenchymal stem cells which express TNF-? receptor Type I in an amount of at least 13 pg/106 cells. Such mesenchymal stem cells inhibit the proliferation of lymphocytes and may be employed, in particular, in the treatment of graft-versus-host disease.
    Type: Application
    Filed: November 2, 2020
    Publication date: June 10, 2021
    Applicant: Mesoblast International Sárl
    Inventors: Alla DANILKOVITCH, Diane CARTER, Alicia Mildred TYRELL, Simon BUBNIC, Michelle MARCELINO, Rodney MONROY